Articles

Anamnestic, clinical, and dermoscopic predictors of malignancy in melanocytic lesions with peripheral globules: a retrospective study

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 5 March 2025
Accepted: 18 May 2025
Published: 10 June 2025
555
Views
266
Downloads
3
HTML

Authors

Melanocytic lesions with peripheral globules (MLPGs) usually represent lesions in an active growth phase and should be carefully evaluated in adults and the elderly, since melanoma can rarely present with this pattern. The primary aim of this study was to identify anamnestic, clinical, and dermoscopic features associated with malignancy (histologic outcome of melanoma) in MLPGs. The secondary aim was to describe the frequency of these features. We conducted a retrospective cross-sectional observational study, evaluating anamnestic, clinical, and dermoscopic features of MLPGs excised at the Dermatology Clinic of Trieste, Italy (January 2019-June 2023). The association between each variable and the histologic outcome (nevus or melanoma) was assessed using Fisher’s exact test. Differences in age and lesion diameter distribution between nevi and melanomas were analyzed using Student’s t-test for independent variables. Several lesion characteristics were associated with malignancy, including a personal history of melanoma (p=0.0069), localization on the lower limbs (p=0.0215), and lesion diameter ≥6 mm (p=0.0025). Several dermoscopic features were also associated with malignancy, namely non-circumferential peripheral globules (PGs; p=0.0406), regression (p=0.0042), evident vascular pattern/pink areas (p=0.0007), inverse network (p=0.0243), and asymmetric central globules (p=0.0057). Additionally, the comparison between melanoma and nevi groups confirmed that malignant lesions were characterized by a higher mean age at diagnosis (p=0.0237) and a larger mean diameter (p=0.000112). This study provides practical guidance for the management of MLPGs, highlighting that several anamnestic, clinical, and dermoscopic features are suggestive of malignancy.

Downloads

Download data is not yet available.

Citations

1. Lazaridou E, Fotiadou C, Apalla Z. Melanocytic lesions with peripheral globules: still a pitfall in the differential diagnosis of melanoma. J Eur Acad Dermatology Venereol 2021;35:1040.
2. Bajaj S, Dusza SW, Marchetti MA, et al. Growth-Curve Modeling of Nevi With a Peripheral Globular Pattern. JAMA Dermatology 2015;151:1338.
3. Ilut PA, Camela E, Lallas K, et al. The Natural Evolution of Nevi with Peripheral Globules. Dermatology 2023:1-8.
4. Zalaudek I, Schmid K, Marghoob AA, et al. Frequency of Dermoscopic Nevus Subtypes by Age and Body Site. Arch Dermatol 2011;147:663.
5. Zalaudek I, Catricalà C, Moscarella E, Argenziano G. What dermoscopy tells us about nevogenesis. J Dermatol 2011;38:16-24.
6. Carr S, Smith C, Wernberg J. Epidemiology and Risk Factors of Melanoma. Surg Clin North Am 2020;100:1-12.
7. Conforti C, Zalaudek I. Epidemiology and Risk Factors of Melanoma: A Review. Dermatol Pract Concept 2021:2021161S.
8. Reiter O, Chousakos E, Kurtansky N, et al. Association between the dermoscopic morphology of peripheral globules and melanocytic lesion diagnosis. J Eur Acad Dermatology Venereol 2021;35:892-9.
9. Moraes AFA, Blumetti TCMP, Pinto C, et al. Melanoma with peripheral globules: Clinical and dermatoscopic features. J Am Acad Dermatol 2022;87:567-72.
10. Pampín Franco A, Gamo Villegas R, Floristán Muruzábal U, et al. Melanocytic lesions with peripheral globules: results of an observational prospective study in 154 high-risk melanoma patients under digital dermoscopy follow-up evaluated with reflectance confocal microscopy. J Eur Acad Dermatology Venereol 2021;35:1133-42.
11. Cappilli S, Ribero S, Cornacchia L, et al. Melanocytic Lesions With Peripheral Globules: Proposal Of An Integrated Management Algorithm. Dermatol Pract Concept 2023:e2023010.
12. Raimondi S, Suppa M, Gandini S. Melanoma Epidemiology and Sun Exposure. Acta Derm Venereol 2020;100:adv00136.
13. Rigel DS, Russak J, Friedman R. The Evolution of Melanoma Diagnosis: 25 Years Beyond the ABCDs. CA Cancer J Clin 2010;60:301-16.
14. Ribero S, Moscarella E, Ferrara G, et al. Regression in cutaneous melanoma: a comprehensive review from diagnosis to prognosis. J Eur Acad Dermatol Venereol 2016;30:2030-7.
15. Jour G, Ivan D, Aung PP. Angiogenesis in melanoma: an update with a focus on current targeted therapies. J Clin Pathol 2016;69:472-83.
16. Russo T, Piccolo V, Ferrara G, et al. Dermoscopy pathology correlation in melanoma. J Dermatol 2017;44:507-14.
17. Wolner ZJ, Yélamos O, Liopyris K, et al. Enhancing Skin Cancer Diagnosis with Dermoscopy. Dermatol Clin 2017;35:417-37.
18. Neila J, Soyer HP. Key points in dermoscopy for diagnosis of melanomas, including difficult to diagnose melanomas, on the trunk and extremities. J Dermatol 2011;38:3-9.
19. Pizzichetta MA, Talamini R, Marghoob AA, et al. Negative pigment network: An additional dermoscopic feature for the diagnosis of melanoma. J Am Acad Dermatol 2013;68:552-9.
20. Xu J, Gupta K, Stoecker WV, et al. Analysis of Globule Types in Malignant Melanoma. Arch Dermatol 2009;145.

How to Cite



1.
Zelin E, Mazzoletti V, Paladin J, Corio A, Caposiena Caro RD, Bazzacco G, et al. Anamnestic, clinical, and dermoscopic predictors of malignancy in melanocytic lesions with peripheral globules: a retrospective study. Dermatol Reports [Internet]. 2025 Jun. 10 [cited 2026 Apr. 5];18(1). Available from: https://journals.pagepress.net/dr/article/view/10334